David Terrano
@david_terrano
Dermatopathologist and Medical Director. Trained scientist. Raised in Northfield, Ohio. Tweets my own.
ID:1013515226
15-12-2012 16:24:01
16,3K Tweets
2,4K Followers
848 Following
Say it again Andrew Bellizzi 🇺🇦. I do love IHC though…appropriate and minimal rule-in and rule-out application is still a target goal of mine. Getting there slowly…
Matthew Wasco This change is so unecessary. Rationale is to improve uptake of AS. In the UK, 95% of low risk 3+3 patients are managed with AS (compared to <50% in USA) largely thanks to our excellent cancer nurses. Better patient education is better than confusing nomenclature change.